Clinical Trial: Early Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of STR-P005

U.S., May 27 -- ClinicalTrials.gov registry received information related to the study (NCT07605637) titled 'Early Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of STR-P005' on May 12.

Brief Summary: This is a single-center, single-arm, open-label, investigator-initiated early exploratory clinical trial designed to evaluate the safety and efficacy of STR-P005 in participants with relapsed/refractory autoimmune diseases.

The study will employ a traditional "3+3" dose-escalation design, with 3 dose groups: XXmg/kg, XXmg/kg, XXmg/kg. Dose Group 1 is the starting dose. This group includes two cohorts, A and B, to optimize the dosing frequency of STR-P005. Cohort A will receive doses Q3D (once every 3 days) on ...